These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 27639544

  • 1. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.
    Banerjee K, Das S, Sarkar A, Chatterjee M, Biswas J, Choudhuri SK.
    Biomed Pharmacother; 2016 Dec; 84():71-92. PubMed ID: 27639544
    [Abstract] [Full Text] [Related]

  • 2. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K, Biswas MK, Choudhuri SK.
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [Abstract] [Full Text] [Related]

  • 3. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K, Basu S, Das S, Sinha A, Biswas MK, Choudhuri SK.
    Free Radic Res; 2016 Dec; 50(4):426-46. PubMed ID: 26733073
    [Abstract] [Full Text] [Related]

  • 4. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A, Basu S, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Chaudhuri SK.
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [Abstract] [Full Text] [Related]

  • 5. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
    Ganguly A, Banerjee K, Chakraborty P, Das S, Sarkar A, Hazra A, Banerjee M, Maity A, Chatterjee M, Mondal NB, Choudhuri SK.
    Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
    [Abstract] [Full Text] [Related]

  • 6. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
    Lonetti A, Cappellini A, Bertaina A, Locatelli F, Pession A, Buontempo F, Evangelisti C, Evangelisti C, Orsini E, Zambonin L, Neri LM, Martelli AM, Chiarini F.
    J Hematol Oncol; 2016 Oct 24; 9(1):114. PubMed ID: 27776559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A zinc Schiff base complex inhibits cancer progression both in vivo and in vitro by inducing apoptosis.
    Banerjee A, Banerjee K, Sinha A, Das S, Majumder S, Majumdar S, Choudhuri SK.
    Environ Toxicol Pharmacol; 2017 Dec 24; 56():383-392. PubMed ID: 29145169
    [Abstract] [Full Text] [Related]

  • 10. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T, Yao S, Zhang X, Guo Y.
    Drug Des Devel Ther; 2016 Dec 24; 10():1389-97. PubMed ID: 27114702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W, Zhao J, Chen W, Shang H, Peng J, Lin J.
    Anticancer Agents Med Chem; 2021 Dec 24; 21(15):1987-1995. PubMed ID: 33438566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
    Mendes RD, Canté-Barrett K, Pieters R, Meijerink JP.
    Haematologica; 2016 Sep 24; 101(9):1010-7. PubMed ID: 27582570
    [Abstract] [Full Text] [Related]

  • 17. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
    Ghosh RD, Banerjee K, Das S, Ganguly A, Chakraborty P, Sarkar A, Chatterjee M, Choudhuri SK.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):737-47. PubMed ID: 23665413
    [Abstract] [Full Text] [Related]

  • 18. Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
    Siqueira RP, Caetano MMM, de Souza LÂ, Dos Passos PMS, Simaroli NB, Barros MVA, de Souza APM, de Oliveira LL, Silva-Júnior A, Fietto JLR, Teixeira RR, Teixeira FR, Bressan GC.
    Toxicol In Vitro; 2020 Jun 16; 65():104777. PubMed ID: 31962201
    [Abstract] [Full Text] [Related]

  • 19. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 20. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD, Das S, Ganguly A, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Nanda A, Pradhan K, Choudhuri SK.
    Dalton Trans; 2011 Nov 07; 40(41):10873-84. PubMed ID: 21717020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.